section name header

Use and Dosing

Adult Dosingnavigator.gif

Hypertension

Initial therapy

Add-On therapy

Replacement therapy

Pediatric Dosingnavigator.gif


[Outline]

Indications

Contraindications

Black Box Warnings

Dosing Adjustment

Renal Dose Adjustment

Hepatic Dose Adjustment

Warnings/Precautions

See Supplemental Patient Information

Cautions: Use cautiously in

Supplemental Patient Information

Pregnancy/Breast Feeding

Pregnancy Category:C (First trimester); D (Second and third trimester )

Breastfeeding: Safety unknown; prefer an alternative drug during breastfeeding as appropriate literature on the use of amlodipine as well as telmisartan is unavailable. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 14 December 2010). According to the manufacturer data, it is not known whether amlodipine and telmisartan are excreted in human milk. It is recommended to discontinue nursing while amlodipine is administered. Due to the potential for serious adverse reactions in nursing infants, manufacturer recommends discontinuation of nursing or discontinuation of telmisartan, taking into account the importance of the drug to the mother.

Adverse Reactions

Clinical Pharmacology

Amlodipine

Telmisartan

Brands and Availability

flag_usa32.png

US Trade Name(s)

US Availability

amlodipine/telmisartan (generic)

Twynsta (amlodipine/telmisartan)

flag_canada32.png

Canadian Trade Name(s)

Canadian Availability

flag_uk32.png

UK Trade Name(s)

UK Availability

flag_australia32.png

Australian Trade Name(s)

Australian Availability


[Outline]

flag_usa32.pngflag_canada32.pngflag_uk32.pngflag_australia32.png

Classification

Cardiovascular

Antihypertensive Combinations

Pricing

Pricing data from www.DrugStore.com in U.S.A.

Warning.gifWarning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.

Pill